Roanoke Times Copyright (c) 1995, Landmark Communications, Inc. DATE: THURSDAY, December 29, 1994 TAG: 9412290117 SECTION: NATIONAL/INTERNATIONAL PAGE: A-7 EDITION: METRO SOURCE: DATELINE: WASHINGTON LENGTH: Short
Lamotrigine, sold by Burroughs Wellcome Co. under the brand name Lamictal, was approved Wednesday as adjunctive therapy to control partial seizures - the most common epilepsy type - in adults.
About 2 million Americans have epilepsy, a nervous system disorder. Medication brings the resulting seizures under control for many. But about 30 percent of partial-seizure sufferers still experience breakthrough seizures despite taking two or more drugs.
- Associated Press
by CNB